Preoperative risk assessment and prevention of complications in patients with esophageal cancer

Journal of Surgical Oncology

Volumn 101, Issue 3, 2010, Pages 270-278

  Grotenhuis, Brechtje A ^a   Wijnhoven, Bas P L ^a   Grüne, Frank ^a   Van Bommel, Jasper ^a   Tilanus, Hugo W ^a   Van Lanschot, J Jan B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Complication prevention; Esophagectomy; Perioperative risk analysis; Risk factors

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIARRHYTHMIC AGENT; ANTINEOPLASTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ANASTOMOSIS LEAKAGE; ANESTHESIST; ATELECTASIS; BLEEDING; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CLINICAL TRIAL; CONDUIT NECROSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FLUID THERAPY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HUMAN; IMMUNE DEFICIENCY; INTRAOPERATIVE PERIOD; LOW DRUG DOSE; NECROSIS; NUTRITIONAL STATUS; PATIENT SELECTION; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; POSTOPERATIVE PAIN; PREDICTOR VARIABLE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROPHYLAXIS; RESPIRATORY FAILURE; RESPIRATORY SYSTEM; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SCORING SYSTEM; STROKE; SURGEON;

ADULT; AGED; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; HUMANS; MALNUTRITION; MIDDLE AGED; NEOADJUVANT THERAPY; NUTRITIONAL STATUS; OBESITY; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; RISK FACTORS;

EID: 77249134211     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21471     Document Type: Review

References (96)

1. Hulscher JB, van Sandick JW, de Boer AG, et al.: Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002; 347:1662-1669.
2. Whooley BP, Law S, Murthy SC, et al.: Analysis of reduced death and complication rates after esophageal resection. Ann Surg 2001;233:338-344.
3. Siewert JR, Feith M, Werner M, et al.: Adenocarcinoma of the esophagogastric junction: Results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 2000;232:353-361.
4. Siewert JR, Stein HJ, Feith M, et al.: Histologic tumor type is an independent prognostic parameter in esophageal cancer: Lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg 2001;234:360-367, discussion 368-369.
5. Lerut T, De Leyn P, Coosemans W, et al.: Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg 1992;216:583-590.
6. van Lanschot JJ, Hulscher JB, Buskens CJ, et al.: Hospital volume and hospital mortality for esophagectomy. Cancer 2001;91:1574-1578.
7. WoutersMW,Wijnhoven BP, Karim-Kos HE, et al.: High-volume versus low-volume for esophageal resections for cancer: The essential role of case-mix adjustments based on clinical data. Ann Surg Oncol 2008;15:80-87.
8. Sauvanet A, Mariette C, Thomas P, et al.: Mortality and morbidity after resection for adenocarcinoma of the gastroesophageal junction: Predictive factors. J Am Coll Surg 2005;201:253-262.
9. Ferguson MK, Martin TR, Reeder LB, et al.: Mortality after esophagectomy: Risk factor analysis.World J Surg 1997;21:599-603, discussion 603-604.
10. Abunasra H, Lewis S, Beggs L, et al.: Predictors of operative death after oesophagectomy for carcinoma. Br J Surg 2005;92: 1029-1033.
11. Avendano CE, Flume PA, Silvestri GA, et al.: Pulmonary complications after esophagectomy. Ann Thorac Surg 2002;73: 922-926.
12. Bailey SH, Bull DA, Harpole DH, et al.: Outcomes after esophagectomy: A ten-year prospective cohort. Ann Thorac Surg 2003;75:217-222, discussion 222.
13. Jougon JB, Ballester M, Duffy J, et al.: Esophagectomy for cancer in the patient aged 70 years and older. Ann Thorac Surg 1997; 63:1423-1427.
14. Ruol A, Portale G, Zaninotto G, et al.: Results of esophagectomy for esophageal cancer in elderly patients: Age has little influence on outcome and survival. J Thorac Cardiovasc Surg 2007;133: 1186-1192.
15. Poon RT, Law SY, Chu KM, et al.: Esophagectomy for carcinoma of the esophagus in the elderly: Results of current surgical management. Ann Surg 1998;227:357-364.
16. Adam DJ, Craig SR, Sang CT, et al.: Esophagectomy for carcinoma in the octogenarian. Ann Thorac Surg 1996;61:190-194.
17. Moskovitz AH, Rizk NP, Venkatraman E, et al.: Mortality increases for octogenarians undergoing esophagogastrectomy for esophageal cancer. Ann Thorac Surg 2006;82:2031-2036, discussion 2036.
18. Ruol A, Portale G, Castoro C, et al.: Management of esophageal cancer in patients aged over 80 years. Eur J Cardiothorac Surg 2007;32:445-448.
19. Dunlop WE, Rosenblood L, Lawrason L, et al.: Effects of age and severity of illness on outcome and length of stay in geriatric surgical patients. Am J Surg 1993;165:577-580.
20. Law S, Wong KH, Kwok KF, et al.: Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg 2004;240:791-800.
21. Ferguson MK, Durkin AE: Preoperative prediction of the risk of pulmonary complications after esophagectomy for cancer. J Thorac Cardiovasc Surg 2002;123:661-669.
22. van Sandick JW, Gisbertz SS, ten Berge IJ, et al.: Immune responses and prediction of major infection in patients undergoing transhiatal or transthoracic esophagectomy for cancer. Ann Surg 2003;237:35-43.
23. Hulscher JB, van Sandick JW, Devriese PP, et al.: Vocal cord paralysis after subtotal oesophagectomy. Br J Surg 1999;86: 1583-1587.
24. Kuwano H, Sumiyoshi K, Sonoda K, et al.: Relationship between preoperative assessment of organ function and postoperative morbidity in patients with oesophageal cancer. Eur J Surg 1998;164:581-586.
25. Smetana GW, Lawrence VA, Cornell JE: Preoperative pulmonary risk stratification for noncardiothoracic surgery: Systematic review for the American College of Physicians. Ann Intern Med 2006;144:581-595.
26. Nomori H, Kobayashi R, Fuyuno G, et al.: Preoperative respiratory muscle training. Assessment in thoracic surgery patients with special reference to postoperative pulmonary complications. Chest 1994;105:1782-1788.
27. Hulzebos EH, Helders PJ, Favie NJ, et al.: Preoperative intensive inspiratory muscle training to prevent postoperative pulmonary complications in high-risk patients undergoing CABG surgery: A randomized clinical trial. JAMA 2006;296:1851-1857.
28. Murthy SC, Law S, Whooley BP, et al.: Atrial fibrillation after esophagectomy is a marker for postoperative morbidity and mortality. J Thorac Cardiovasc Surg 2003;126:1162-1167.
29. Lee TH, Marcantonio ER, Mangione CM, et al.: Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999;100:1043-1049.
30. Schinkel AF, Poldermans D, Elhendy A, et al.: Prognostic role of dobutamine stress echocardiography in myocardial viability. Curr Opin Cardiol 2006;21:443-449.
31. Forshaw MJ, Strauss DC, Davies AR, et al.: Is cardiopulmonary exercise testing a useful test before esophagectomy? Ann Thorac Surg 2008;85:294-299.
32. Lindenauer PK, Pekow P, Wang K, et al.: Perioperative betablocker therapy and mortality after major noncardiac surgery. N Engl J Med 2005;353:349-361.
33. Bangalore S, Wetterslev J, Pranesh S, et al.: Perioperative beta blockers in patients having non-cardiac surgery: A meta-analysis. Lancet 2008;372:1962-1976.
34. Lopez-Sendon J, Swedberg K, McMurray J, et al.: Expert consensus document on beta-adrenergic receptor blockers. Eur Heart J 2004;25:1341-1362.
35. Amar D, Zhang H, Heerdt PM, et al.: Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein. Chest 2005;128:3421-3427.
36. Lindenauer PK, Pekow P, Wang K, et al.: Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA 2004;291:2092-2099.
37. Le Manach Y, Godet G, Coriat P, et al.: The impact of postoperative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery. Anesth Analg 2007;104:1326-1333, table of contents.
38. Burger W, Chemnitius JM, Kneissl GD, et al.: Low-dose aspirin for secondary cardiovascular prevention-Cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation-Review and meta-analysis. J Intern Med 2005;257: 399-414.
39. Llau JV, Lopez-Forte C, Sapena L, et al.: Perioperative management of antiplatelet agents in noncardiac surgery. Eur J Anaesthesiol 2009;26:181-187.
40. Chassot PG, Delabays A, Spahn DR: Perioperative use of antiplatelet drugs. Best Pract Res Clin Anaesthesiol 2007;21:241-256.
41. O'Riordan JM, Margey RJ, Blake G, et al.: Antiplatelet agents in the perioperative period. Arch Surg 2009;144:69-76, discussion 76.
42. McDonagh TA, Robb SD, Murdoch DR, et al.: Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998; 351:9-13.
43. Hou JL, Gao K, Li M, et al.: Increased N-terminal pro-brain natriuretic peptide level predicts atrial fibrillation after surgery for esophageal carcinoma. World J Gastroenterol 2008;14:2582-2585.
44. Fleisher LA, Beckman JA, Brown KA, et al.: ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 2007;116:1971-1996.
45. Adams JP, Murphy PG: Obesity in anaesthesia and intensive care. Br J Anaesth 2000;85:91-108.
46. Healy LA, Ryan AM, Gopinath B, et al.: Impact of obesity on outcomes in the management of localized adenocarcinoma of the esophagus and esophagogastric junction. J Thorac Cardiovasc Surg 2007;134:1284-1291.
47. Scipione CN, Chang AC, Pickens A, et al.: Transhiatal esophagectomy in the profoundly obese: Implications and experience. Ann Thorac Surg 2007;84:376-382, discussion 383.
48. Morgan MA, Lewis WG, Hopper AN, et al.: Prognostic significance of body mass indices for patients undergoing esophagectomy for cancer. Dis Esophagus 2007;20:29-35.
49. Heys SD, Schofield AC, Wahle KW, et al.: the surgical patient: Triumphs and challenges. Surgeon 2005;3:139-144.
50. Han-Geurts IJ, Hop WC, Tran TC, et al.: Nutritional status as a risk factor in esophageal surgery. Dig Surg 2006;23:159-163.
51. Gibbs J, CullW, HendersonW, et al.: Preoperative serum albumin level as a predictor of operative mortality and morbidity: Results from the National VA Surgical Risk Study. Arch Surg 1999; 134:36-42.
52. Kudsk KA, Tolley EA, DeWitt RC, et al.: Preoperative albumin and surgical site identify surgical risk for major postoperative complications. JPEN J Parenter Enteral Nutr 2003;27:1-9.
53. Ryan AM, Hearty A, Prichard RS, et al.: Association of hypoalbuminemia on the first postoperative day and complications following esophagectomy. J Gastrointest Surg 2007;11: 1355-1360.
54. Keller SM, Ryan LM, Coia LR, et al.: High dose chemoradiotherapy followed by esophagectomy for adenocarcinoma of the esophagus and gastroesophageal junction: Results of a phase II study of the Eastern Cooperative Oncology Group. Cancer 1998;83:1908-1916.
55. Heidecke CD, Weighardt H, Feith M, et al.: Neoadjuvant treatment of esophageal cancer: Immunosuppression following combined radiochemotherapy. Surgery 2002;132:495-501.
56. Fiorica F, Di Bona D, Schepis F, et al.: Preoperative chemoradiotherapy for oesophageal cancer: A systematic review and meta-analysis. Gut 2004;53:925-930.
57. Kaklamanos IG, Walker GR, Ferry K, et al.: Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: A meta-analysis of randomized clinical trials. Ann Surg Oncol 2003;10:754-761.
58. Urschel JD, Vasan H, Blewett CJ: A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2002;183:274-279.
59. Copeland GP: The POSSUM system of surgical audit. Arch Surg 2002;137:15-19.
60. Tekkis PP, McCulloch P, Poloniecki JD, et al.: Risk-adjusted prediction of operative mortality in oesophagogastric surgery with O-POSSUM. Br J Surg 2004;91:288-295.
61. Lagarde SM, Maris AK, de Castro SM, et al.: Evaluation of OPOSSUM in predicting in-hospital mortality after resection for oesophageal cancer. Br J Surg 2007;94:1521-1526.
62. Zafirellis KD, Fountoulakis A, Dolan K, et al.: Evaluation of POSSUM in patients with oesophageal cancer undergoing resection. Br J Surg 2002;89:1150-1155.
63. Bartels H, Stein HJ, Siewert JR: Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg 1998;85:840-844.
64. Ra J, Paulson EC, Kucharczuk J, et al.: Postoperative mortality after esophagectomy for cancer: Development of a preoperative risk prediction model. Ann Surg Oncol 2008;15:1577-1584.
65. Steyerberg EW, Neville BA, Koppert LB, et al.: Surgical mortality in patients with esophageal cancer: Development and validation of a simple risk score. J Clin Oncol 2006;24:4277-4284.
66. Zingg U, Langton C, Addison B, et al.: Risk prediction scores for postoperative mortality after esophagectomy: Validation of different models. J Gastrointest Surg 2009;2009:611-618.
67. Lagarde SM, Reitsma JB, Maris AK, et al.: Preoperative prediction of the occurrence and severity of complications after esophagectomy for cancer with use of a nomogram. Ann Thorac Surg 2008;85:1938-1945.
68. Tandon S, Batchelor A, Bullock R, et al.: Peri-operative risk factors for acute lung injury after elective oesophagectomy. Br J Anaesth 2001;86:633-638.
69. Tachibana M, Abe S, Tabara H, et al.: One-lung or two-lung ventilation during transthoracic oesophagectomy? Can J Anaesth 1994;41:710-715.
70. Sanjay PS, Miller SA, Corry PR, et al.: The effect of gel lubrication on cuff leakage of double lumen tubes during thoracic surgery. Anaesthesia 2006;61:133-137.
71. Shackcloth MJ, McCarron E, Kendall J, et al.: Randomized clinical trial to determine the effect of nasogastric drainage on tracheal acid aspiration following oesophagectomy. Br J Surg 2006;93:547-552.
72. Holte K, Sharrock NE, Kehlet H: Pathophysiology and clinical implications of perioperative fluid excess. Br J Anaesth 2002;89: 622-632.
73. Kita T, Mammoto T, Kishi Y: Fluid management and postoperative respiratory disturbances in patients with transthoracic esophagectomy for carcinoma. J Clin Anesth 2002;14:252-256.
74. Neal JM,Wilcox RT, AllenHW, et al.: Near-total esophagectomy: The influence of standardized multimodal management and intraoperative fluid restriction. Reg Anesth Pain Med 2003;28: 328-334.
75. Sato N, Koeda K, Ikeda K, et al.: Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer. Ann Surg 2002;236:184-190.
76. Flisberg P, Tornebrandt K, Walther B, et al.: Pain relief after esophagectomy: Thoracic epidural analgesia is better than parenteral opioids. J Cardiothorac Vasc Anesth 2001;15:282-287.
77. Rudin A, Flisberg P, Johansson J, et al.: Thoracic epidural analgesia or intravenous morphine analgesia after thoracoabdominal esophagectomy: A prospective follow-up of 201 patients. J Cardiothorac Vasc Anesth 2005;19:350-357.
78. Brodner G, Pogatzki E, Van Aken H, et al.: A multimodal approach to control postoperative pathophysiology and rehabilitation in patients undergoing abdominothoracic esophagectomy. Anesth Analg 1998;86:228-234.
79. Cense HA, Lagarde SM, de Jong K, et al.: Association of no epidural analgesia with postoperative morbidity and mortality after transthoracic esophageal cancer resection. J Am Coll Surg 2006;202:395-400.
80. Omloo JM, Lagarde SM, Hulscher JB, et al.: Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: Five-year survival of a randomized clinical trial. Ann Surg 2007;246:992-1000, discussion 1000-1001.
81. Hulscher JB, Tijssen JG, Obertop H, et al.: Transthoracic versus transhiatal resection for carcinoma of the esophagus: A metaanalysis. Ann Thorac Surg 2001;72:306-313.
82. Isono K, Sato H, Nakayama K: Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology 1991;48:411-420.
83. Kato H, Watanabe H, Tachimori Y, et al.: Evaluation of neck lymph node dissection for thoracic esophageal carcinoma. Ann Thorac Surg 1991;51:931-935.
84. Law S, Wong J: Two-field dissection is enough for esophageal cancer. Dis Esophagus 2001;14:98-103.
85. Fujita H, Kakegawa T, Yamana H, et al.: Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Comparison of three-field lymphadenectomy with two-field lymphadenectomy. Ann Surg 1995;222:654-662.
86. Ikeda Y, Niimi M, Kan S, et al.: Clinical significance of tissue blood flow during esophagectomy by laser Doppler flowmetry. J Thorac Cardiovasc Surg 2001;122:1101-1106.
87. Miyazaki T, Kuwano H, Kato H, et al.: Predictive value of blood flow in the gastric tube in anastomotic insufficiency after thoracic esophagectomy. World J Surg 2002;26:1319-1323.
88. Hölscher AH, Vallbohmer D, Brabender J: The prevention and management of perioperative complications. Best Pract Res Clin Gastroenterol 2006;20:907-923.
89. Law S, Fok M, Chu KM, et al.: Comparison of hand-sewn and stapled esophagogastric anastomosis after esophageal resection for cancer: A prospective randomized controlled trial. Ann Surg 1997;226:169-173.
90. Hsu HH, Chen JS, Huang PM, et al.: Comparison of manual and mechanical cervical esophagogastric anastomosis after esophageal resection for squamous cell carcinoma: A prospective randomized controlled trial. Eur J Cardiothorac Surg 2004;25: 1097-1101.
91. Ercan S, Rice TW, Murthy SC, et al.: Does esophagogastric anastomotic technique influence the outcome of patients with esophageal cancer? J Thorac Cardiovasc Surg 2005;129:623-631.
92. Briel JW, Tamhankar AP, Hagen JA, et al.: Prevalence and risk factors for ischemia, leak, and stricture of esophageal anastomosis: Gastric pull-up versus colon interposition. J Am Coll Surg 2004;198:536-541, discussion 541-542.
93. Matsuzaki Y, Edagawa M, Maeda M, et al.: Beneficial effect of prostaglandin E1 on blood flow to the gastric tube after esophagectomy. Ann Thorac Surg 1999;67:908-910.
94. Buise M, van Bommel J, Jahn A, et al.: Intravenous nitroglycerin does not preserve gastric microcirculation during gastric tube reconstruction: A randomized controlled trial. Crit Care 2006; 10:R131.
95. Urschel JD: Esophagogastric anastomotic leaks: The importance of gastric ischemia and therapeutic applications of gastric conditioning. J Invest Surg 1998;11:245-250.
96. Hölscher AH, Schneider PM, Gutschow C, et al.: Laparoscopic ischemic conditioning of the stomach for esophageal replacement. Ann Surg 2007;245:241-246.